J. Goldman & Co’s BioAmber Inc. BIOA Stock Holding History

J. Goldman & Co’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-126,900	Closed	-$863K	–	367
2013 Q2	$863K	Buy	+126,900	New	+$944K	0.09%	193

Other funds holding BIOA

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

ACPU

Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

J. Goldman & Co's BIOA Position: Q3 2013 in Review

J. Goldman & Co sold out of BioAmber Inc. (BIOA) in Q3 2013, closing a stake of 126,900 shares — an estimated $863K sold.

J. Goldman & Co first reported a position in BIOA in Q2 2013 and held it in 1 quarter. The position peaked at $863K in Q2 2013. 15 funds tracked by Wall St. Rank hold BIOA as of Q3 2013.

J. Goldman & Co reported no remaining BioAmber Inc. position as of Q3 2013 after selling out during the quarter.
J. Goldman & Co sold 126,900 BioAmber Inc. shares in Q3 2013, an estimated $863K.
J. Goldman & Co first reported a position in BioAmber Inc. in Q2 2013 and held it in 1 quarter.
J. Goldman & Co's BioAmber Inc. position peaked at $863K in Q2 2013.
15 funds tracked by Wall St. Rank held BioAmber Inc. as of Q3 2013.

Based on J. Goldman & Co's 13F filing for Q3 2013, filed 14 Nov 2013.